Current Diabetes Reports

, Volume 12, Issue 1, pp 75–81

Type 2 Diabetes in Childhood: Clinical Characteristics and Role of β-Cell Autoimmunity

Pediatric Type 2 Diabetes (M Freemark, Section Editor)

DOI: 10.1007/s11892-011-0247-2

Cite this article as:
Badaru, A. & Pihoker, C. Curr Diab Rep (2012) 12: 75. doi:10.1007/s11892-011-0247-2


The global obesity epidemic has led to dramatic increases in the incidence and prevalence of type 2 diabetes mellitus (T2DM) among youth worldwide. In today’s clinical practice it has become increasingly difficult to distinguish type 1 diabetes mellitus (T1DM) from T2DM as many children with T1DM are overweight at diagnosis. Numerous recent publications note a significant proportion of physician-diagnosed T2DM youth with evidence of pancreatic autoimmunity, exemplifying the challenges in distinguishing between T1DM and T2DM. The clinical implications of the phenomenon of antibody positivity in phenotypic T2DM youth, also referred to as “type 1.5 diabetes” (T1.5 DM), “double diabetes,” “latent autoimmune diabetes in youth” (LADY), and “hybrid diabetes,” are unclear at present. Current and future work should determine if the presence of autoantibodies in phenotypic T2DM youth/children affects clinical course; this will facilitate the development of optimal treatment strategies.


Type 2 diabetes in youth Type 1.5 diabetes Diabetes autoantibodies Antibody-positive phenotypic T2DM youth Accelerator hypothesis β-cell autoimmunity 

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Department of PediatricsUniversity of WashingtonSeattleUSA
  2. 2.Division of EndocrinologySeattle Children’s HospitalSeattleUSA

Personalised recommendations